Whole transcriptome analysis comparing HR+ HER2- breast cancer tumors from patients < 50 years and >50 years.
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2021.39.15_suppl.565
Abstract: 565Background: Recent prospective clinical trials have demonstrated a differential chemotherapy effect based on age (≤ 50 vs. > 50 years) or menopausal status (pre- vs. post-) in a genomic low risk... read more here.
Keywords: comparing her2; transcriptome analysis; her2 breast; whole transcriptome ... See more keywords